0.3
2021-05-30
This version allows the customization of daily check-ins to show sickle cell specific treatments for which to assess adherence. Current possibilities include assessment of adherence to hydroxyurea, Oxbryta, or ENDARI, all treatments that are usually prescribed to be taken at least once a daily.